ATE308976T1 - Lungensurfactant zubereitungen enthaltendes behandlungset - Google Patents

Lungensurfactant zubereitungen enthaltendes behandlungset

Info

Publication number
ATE308976T1
ATE308976T1 AT99971701T AT99971701T ATE308976T1 AT E308976 T1 ATE308976 T1 AT E308976T1 AT 99971701 T AT99971701 T AT 99971701T AT 99971701 T AT99971701 T AT 99971701T AT E308976 T1 ATE308976 T1 AT E308976T1
Authority
AT
Austria
Prior art keywords
set containing
lung surfactant
treatment set
surfactant preparations
containing lung
Prior art date
Application number
AT99971701T
Other languages
English (en)
Inventor
Paul-Georg Germann
Herbert Rupp
Klaus Eistetter
Ulrich Kilian
Dietrich Haefner
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE308976T1 publication Critical patent/ATE308976T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99971701T 1998-11-10 1999-11-09 Lungensurfactant zubereitungen enthaltendes behandlungset ATE308976T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98121324 1998-11-10
PCT/EP1999/008567 WO2000027360A1 (en) 1998-11-10 1999-11-09 Treatment set containing lungsurfactant compositions

Publications (1)

Publication Number Publication Date
ATE308976T1 true ATE308976T1 (de) 2005-11-15

Family

ID=8232946

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99971701T ATE308976T1 (de) 1998-11-10 1999-11-09 Lungensurfactant zubereitungen enthaltendes behandlungset

Country Status (7)

Country Link
EP (1) EP1131055B1 (de)
JP (1) JP2002529394A (de)
AT (1) ATE308976T1 (de)
AU (1) AU1161300A (de)
DE (1) DE69928279T2 (de)
ES (1) ES2253003T3 (de)
WO (1) WO2000027360A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001265876A1 (en) * 2000-04-12 2001-10-23 Byk Gulden Lomberg Chemische Fabrik G.M.B.H. Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
SE0203591D0 (sv) * 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
WO2004110450A1 (en) * 2003-06-16 2004-12-23 Altana Pharma Ag Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
CA2549160A1 (en) * 2003-12-04 2005-06-23 The Scripps Research Institute Treatment and preventions of asthma
JP5108515B2 (ja) * 2004-08-06 2012-12-26 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 肺サーファクタント及びｔｎｆ由来ペプチドを含有する組成物
AU2005282065B2 (en) * 2004-09-10 2013-02-07 Pharmaorigin Aps Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis
CA2637644A1 (en) * 2006-01-23 2007-08-02 Pneuma Partners, Llc. Treatment of acute respiratory distress syndrome
WO2008011559A2 (en) 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
US8206687B2 (en) 2006-10-26 2012-06-26 Next Breath, Llc Phospholipid-based inhalation system
MX354829B (es) * 2009-03-26 2018-03-22 Pulmatrix Operating Co Inc Formulaciones de polvo seco y metodos para el tratamiento de enfermedades pulmonares.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165821A (ja) * 1984-09-07 1986-04-04 Tokyo Tanabe Co Ltd 合成サ−フアクタント及びそれを有効成分とする肺表面活性物質喪失性無気肺の治療剤
JPH05294996A (ja) * 1992-04-17 1993-11-09 Tokyo Tanabe Co Ltd 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤
US6315983B1 (en) * 1996-01-24 2001-11-13 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for the production of powdered pulmonary surfactant preparations

Also Published As

Publication number Publication date
EP1131055B1 (de) 2005-11-09
AU1161300A (en) 2000-05-29
EP1131055A1 (de) 2001-09-12
ES2253003T3 (es) 2006-05-16
JP2002529394A (ja) 2002-09-10
DE69928279D1 (de) 2005-12-15
WO2000027360A1 (en) 2000-05-18
DE69928279T2 (de) 2006-08-17

Similar Documents

Publication Publication Date Title
BR9811249A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma
DE69928279D1 (de) Lungensurfactant zubereitungen enthaltendes behandlungset
BG103930A (en) Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
NO20061455L (no) 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
AP1450A (en) Solid oral dosage form comprising a combination of metformin and glibenclamide.
DK0682524T3 (da) Farmaceutiske præparater indeholdende et baktericid/permeabilitetsforøgende protein og et afspændingsmiddel
BR0112101A (pt) Interleucina 2 estabilizada
CA2201749A1 (en) Stable aqueous alfa interferon solution formulations
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
HU9600599D0 (en) Active principles and gas containing microparticles
IL130840A (en) Formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml comprising budesonide
MY118345A (en) Repinotan kit
ES2149082A1 (es) Nueva formulacion para inhalacion.
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
NO993407L (no) Fremstilling av proteinpreparater med nedsatt aggregatinnhold
BR9806893A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 a 038 g/ml, compreendendo sulfato de terbutalina, processo para preparação da formulação e uso da mesma
AU586988B2 (en) Solid drug formulations and stable suspensions
YU40398A (sh) Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa
FI911501A0 (fi) Liposomkomposition foer parenteralt bruk.
BG106151A (en) Pharmaceutical complex
AU665397B2 (en) Fungicidal compositions
DK0541780T3 (de)
MD980129A (en) Antiherpetic remedy

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties